SlideShare ist ein Scribd-Unternehmen logo
1 von 70
Using Digital and Social Media
to Influence the #RxProblem
Presenters:
• Rosemary Bretthauer-Mueller, Digital and Social Marketing
Lead, National Center for Injury Prevention and Control, CDC
• Erin Connelly, MPA, Associate Director of Communication,
National Center for Injury Prevention and Control, CDC
• Cassie Strawn, MA, Health Communication Specialist, National
Center for Injury Prevention and Control, CDC
A Centers for Disease Control and Prevention Training:
Disclosures
Erin Connelly, MPAff; Cassie Strawn, MA; and
Rosie Bretthauer-Mueller have disclosed no
relevant, real or apparent personal or
professional financial relationships with
proprietary entities that produce health care
goods and services
Disclosures
• All planners/managers hereby state that they or
their spouse/life partner do not have any financial
relationships or relationships to products or
devices with any commercial interest related to
the content of this activity of any amount during
the past 12 months.
• The following planners/managers have the
following to disclose:
– John J. Dreyzehner, MD, MPH, FACOEM – Ownership
interest: Starfish Health (spouse)
– Robert DuPont – Employment: Bensinger, DuPont &
Associates-Prescription Drug Research Center
Learning Objectives
1. Explain the value and use of general
communication principles, planning and tactics.
2. Demonstrate the basic processes of establishing,
maintaining and using social media channels.
3. Identify social media best practices, with
potential opportunities to expand knowledge
and refine use of channels.
4. Describe the application of social media to help
address public health issues.
5. Explain how to prepare to use social media to
impact the #RxProblem.
Erin Connelly Rosie Bretthauer-Mueller Cassie Strawn
Introductions
Agenda
2:00 pm: Surveys; Introductions; Opioid Overdose Epidemic
Overview; Health Communication Basics; Discussion &
Questions
2:50 pm: Break
3:00 pm: Survey results; Social Media: Basics to Best Practices;
Case Study: #RxProblem; Discussion & Questions
3:50 pm: Break
4:00 pm: Small group exercise; Discussion & Questions
4:50 pm: Wrap up
OPIOID OVERDOSE EPIDEMIC
Nearly a half million
people have died from drug overdoses in the
United States from 2000 to 2014.
Americans die every day from an opioid overdose—
including prescription opioids and heroin.78
249 million
prescriptions were written in 2013—enough for
every adult American to have a bottle of pills.
Opioid Abuse Related Health Issues
 Resurgence of infections like Hepatitis C and HIV
among persons who inject drugs
 Increased sexual risk behavior in youth who misuse and
abuse RX drugs
Reducing Viral Hepatitis Cases Associated
with Drug-Use Behaviors
 To ensure that persons who
inject drugs have access to
viral hepatitis prevention, care
and treatment services, a
comprehensive approach is
needed, including:
– Regular HBV and HCV testing
– Rapid links to care and treatment
– Access to substance abuse
treatment, risk reduction
counseling and sterile injection
equipment
111
3
79
106
185
HIV-, HCV- HIV+, HCV-
HIV+, HCV+ HIV-, HCV+
HIV HCV Outbreak,
Scott County,Indiana,2014-2015
Non-medical use of prescription drugs
among adolescents
 Preventing drug use among adolescents is a priority area for
the Division of Adolescent and School Health (DASH) at CDC.
– Substance abuse has been associated with behaviors that
increase the risk for HIV, sexually transmitted infections (STIs) and
pregnancy.
 In 2011, DASH added a question to the National Youth Risk
Behavior Survey (YRBS) to determine prevalence of non-
medical use of prescription drugs among our nation’s high
school students.
 Data from the 2013 YRBS indicate that about 1 out of 6 high
school students have used prescription drugs without a
doctor’s prescription.
Public health, law enforcement & communities working
together cut crash deaths by more than half...
We can do the same for overdoses
0
5
10
15
20
25
Deathsper100,000population
Motor Vehicle Traffic Drug Poisoning (Overdose)
CDC’s Science and Solutions
 Protect the public by tracking
trends in the epidemic
 Help states scale up prevention
efforts that work
 Improve patient safety by
providing doctors with data and
guidance for evidence-based
decision-making
State Actions Show Promise
Using Communication to Raise Awareness
And to Promote Solutions
www.cdc.gov/drugoverdose
HEALTH COMMUNICATION BASICS
Health Communication Workshop Objectives:
 Define health communication and convey its value
 Understand where health communication fits as an
organizational strategy and as a public health
intervention
 Discuss basic steps involved with executing a health
communication strategy
 Identify the benefits of starting with social media
activities
What is Health Communication?
Using integrated strategies to design and deliver
messages to inform and influence individual and
community decisions that enhance health.
Health communication helps us confront
overwhelming public health challenges.
Health communication is more than just PSAs,
brochures, and presentations.
Information is giving out.
Communication is getting through.
– Sydney J. Harris
Setting the context: where does health
communication fit internally?
Think about your vision, mission and values.
Where does health communication fit internally?
Objectives
Strategies
Goals
Tactics
(The way it will be) (Bringing goals to life)
(Getting the job done) (The path to success)
Where does health communication fit externally?
American Journal of Public Health.2010 Apr; 100(4):590-5
Counseling and Education
Clinical Interventions
Long-Lasting Protective Interventions
Changing the Context
To make individuals’ default decisions healthy
Socioeconomic Factors
Increasing
Population
Impact
Increasing
Individual Effort
Needed
A Campaign That Targets Everyone Targets No One
 No one has unlimited funds.
 Can’t be everything to everyone.
 Must prioritize goals, audiences, messages, channels.
 Focus on a few things each year,
set realistic expectations, and plan
evaluation accordingly.
Now that we have a solid definition and
some valuable context…
Let’s get started.
National Cancer Institute: Making health communication programs work: A planner’s guide. Rev. ed.
1
2
3
4
Planning and Strategy Development
 Review background information to define the problem:
what’s out there?
 Set communication objectives: what do you want to
accomplish?
 Identify primary (and secondary) target audiences: who
do you want to reach?
Developing and Pre-testing Concepts,
Messages and Materials
 Develop and pretest message concepts: what do you
want to say?
 Select communication channels: where do you want to
say it?
 Select, create and pretest messages and products: how
do you want to say it?
Implement the Program
 Develop a promotion and production plan: how do you
get it used?
 Implement communication strategies: get it out there.
Assess Effectiveness and Make Refinements
 Conduct process evaluation: tweak and refine.
 Conduct outcome and impact evaluation: how well did
we do?
In Summary, Communication Efforts
Work Best When They:
 Are integrated into a comprehensive program
 Are based on audience research and pretesting
 Achieve adequate message exposure
 Make strategic use of earned and
social media
 Leverage the power of good storytelling
Why focus on social media?
 It’s accessible
 It can be inexpensive
 It has the potential for large viral reach with the right
content
 It is not going away
Questions?
SOCIAL MEDIA: basics to best practices
Why Social Media for the #RxProblem?
 It’s EASY. (Well…)
 It’s FREE. (Or is it?)
 You have the capacity to do it (Hmm…?)
It’s EASY. (Well…)
 Make the case to your leadership
 Have a plan
– If you build it, will they come?
– Listening
– Engaging
– Policies
Make the case: Who is using social media?
Everybody
 76% of online adults use social media
– 72% use Facebook
– 28% use Instagram
– 23% use Twitter
– 31% use Pinterest
– 25% use LinkedIn
Everyday
 Social media users are vigilant
– 70% of Facebook users use it daily
– 49% of Instagram users use it daily
– 36% of Twitter users use it daily
Make the case: It’s not just cat videos.
 Got their news from Facebook
– 63% in 2015
– 47% in 2013
 Got their news from Twitter
– 63% in 2015
– 52% in 2013
Make the case: What can it do for you?
 Real-time events and info
 Raise awareness
 Connect with your audience
 Expand your reach
 Build new relationships
 Foster conversations
 Harness collective energy
 Support victims, survivors
 Respond to those in need
Have a plan: What do you want to accomplish?
 First, which kind of social media
account is right for you?
– Who is your audience?
– What sort of information do they
want?
– What is their preferred social media
channel?
– What social media channel(s) can you
reasonably launch and maintain?
Have a plan: Which type of account?
Organization
 Official voice
 Organizational content
and security guidelines
 Promote your success
 Share expertise and
resources
Professional Individual
 Face, name, voice
 Personal, identifiable
 Connect with emotions
 Organizational
rules, nuances
Building Followers
 Let your partners know where you will soon be on
social media
 Pair the launch of your social media channel with a
major campaign, meeting, conference
 Use other forms of communication to amplify your new
channel
– Email signature blocks
– Presentations
– Email / newsletters
Listen, Before You Speak
 Find out who else uses your chosen
social media channel
 Like and/or follow them
 Who is already using social media
for the #RxProblem?
Listen, Before You Speak
 Watch conversations about your organization/topics
– Note the questions, opinions, misinformation for content
opportunities
 Subscribe to Lists from trusted
partners
 Search relevant topics through
keywords and hashtags
Plan, Before You Engage
 Types
– Likes
– Shares/retweets
– Comments
– Nothing/ignore
 Process to triage/clear responses
 Decision tree/criteria
– Positive or negative?
– Worth acknowledging?
– Appropriate to respond?
– Add value to conversation?
– Have the content to respond?
– Correct misinformation?
Observing
Following
Engaging
Endorsing
Contributing
Policies Are Part of Your Plan
 Disclaimers
– External comments do not represent you
– Shares do not equal endorsements
 Subject to FOIA notices
 Maintain respectful environment by removing
– Hate speech
– Profanity, obscenity or vulgarity
– Defamation
– Name calling and/or personal attacks
– Comments whose main purpose is to sell a product
– Comments that infringe on copyrights
It’s FREE. (Or is it?)
 Content development
 Monitoring tools
 Advertising
 Staff resources
Content
 It has to be compelling to build a following
 People share when it makes them look:
– Funny
– First-to-know
– Smart…very smart
Content
 If people are looking at Facebook or Twitter every day,
you need content every day.
 You need more content than you think.
 More than that even.
What are people looking for on social media?
What are people looking for on social media?
Keep This in Mind
 Know what works on the
channel
 Keep it simple
 Watch your tone
 Create ways for people to
engage
 Use social media tricks and
tools
 STAY ON MESSAGE
Keep This in Mind
 Create ongoing, engaging
content
 Dedicate resources to
create visual content
 Create content that helps
build a community,
highlighting partners and
leaders in the field
 Create crowdsourced
content through
coordinated events
Monitoring Tools
 Free
 Kinda free
 Not free
Monitoring Tools
 Free
 Kinda free
 Not free
Monitoring Tools
 Free
 Kinda free
 Not free
Why Monitor and Evaluate?
 Review what the audience wants and respond
 Make data-based decisions
 Gauge success
 Improve performance of posts
 Save cost, effective use of staff hours
What are we really measuring?
 Exposure: Visits, views, followers, fans, subscribers,
brand mentions
 Engagement: Clicks, retweets, shares, replies,
messages, posts, comments
 Actions: Downloads, attendees, success stories, leads
 Influence: Share of voice, sentiment, other influencers
Monitor to Know your Audience
 Who are your followers and what do they want?
 What brings in your audiences?
 How much has your audience grown?
 How do they respond to your content?
You have the capacity.
 Get started in social media to your comfort level
 Participate in your organization’s social media process
 Follow your partners/professionals in the field
 Follow/use professional events’ hashtags
 Learn how you can benefit from tying your social media
presence your prevention
 Assess your social media persona before reaching out
to a professional audience
#RXPROBLEM: getting started
Case Study: #RxProblem
 Challenged to help reach influencers
 No resources, short timeline
 Sharable starter content
 Decisions about audience, hashtags
 One chance to launch
Intended Audiences
Who to engage online?
 people whose lives affected
 public health allies
 coalitions and organizations
Who to influence?
 influencers of safer prescribing
 medical and health professionals
 community leaders
Outcomes
 Engage decision makers
 Visibility
 Volume
 Tone
 Quality, appeal
 Create a feeling more
than educate
Questions?
SMALL GROUP EXERCISE
THANK YOU
#RxProblem
@CDCInjury
@DebHouryCDC
CDC.gov/DrugOverdose
CDC’s Injury Center Office of Communication
The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the U.S. Department of
Health and Human Services, or the U.S. Centers for Disease Control and Prevention. Use of trade names and commercial sources is for
identification only and does not constitute endorsement by the U.S. Department of Health and Human Services, or the U.S. Centers for Disease
Control and Prevention.
Using Digital and Social Media
to Influence the #RxProblem
Presenters:
• Rosemary Bretthauer-Mueller, Digital and Social Marketing
Lead, National Center for Injury Prevention and Control, CDC
• Erin Connelly, MPA, Associate Director of Communication,
National Center for Injury Prevention and Control, CDC
• Cassie Strawn, MA, Health Communication Specialist, National
Center for Injury Prevention and Control, CDC
A Centers for Disease Control and Prevention Training:

Weitere ähnliche Inhalte

Was ist angesagt?

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownOPUNITE
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenOPUNITE
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaOPUNITE
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezOPUNITE
 
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdevaView only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdevaOPUNITE
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200OPUNITE
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleOPUNITE
 

Was ist angesagt? (20)

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdevaView only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
 

Andere mochten auch

Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesOPUNITE
 
Rx16 presummit 200_empower_veteransprogram
Rx16 presummit 200_empower_veteransprogramRx16 presummit 200_empower_veteransprogram
Rx16 presummit 200_empower_veteransprogramOPUNITE
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisOPUNITE
 
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...OPUNITE
 
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerRx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerOPUNITE
 
Marathon training injuries and treatment-part1
Marathon training   injuries and treatment-part1Marathon training   injuries and treatment-part1
Marathon training injuries and treatment-part1hamid afroozeh
 
Rx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_groupRx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_groupOPUNITE
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonOPUNITE
 
Rx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-doleRx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-doleOPUNITE
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonOPUNITE
 
Rx16 clinical tues_1115_group
Rx16 clinical tues_1115_groupRx16 clinical tues_1115_group
Rx16 clinical tues_1115_groupOPUNITE
 
Opioids lecture 08
Opioids lecture 08Opioids lecture 08
Opioids lecture 08jamal53
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupOPUNITE
 
Basic neurochemistry
Basic neurochemistryBasic neurochemistry
Basic neurochemistryamitgajjar85
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Introduction to pharmacology and drug metabolism
Introduction to pharmacology and drug metabolismIntroduction to pharmacology and drug metabolism
Introduction to pharmacology and drug metabolismLuke Lightning
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenOPUNITE
 

Andere mochten auch (20)

Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
 
Rx16 presummit 200_empower_veteransprogram
Rx16 presummit 200_empower_veteransprogramRx16 presummit 200_empower_veteransprogram
Rx16 presummit 200_empower_veteransprogram
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
 
Drug addiction and drug abuse
Drug addiction and drug abuseDrug addiction and drug abuse
Drug addiction and drug abuse
 
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
 
Powerpoint Presentation
Powerpoint PresentationPowerpoint Presentation
Powerpoint Presentation
 
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerRx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
 
Marathon training injuries and treatment-part1
Marathon training   injuries and treatment-part1Marathon training   injuries and treatment-part1
Marathon training injuries and treatment-part1
 
Rx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_groupRx16 vs appriss_tues_800_group
Rx16 vs appriss_tues_800_group
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okeson
 
Rx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-doleRx15 pharma wed_430_1_green_2yamada-dole
Rx15 pharma wed_430_1_green_2yamada-dole
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_walton
 
Rx16 clinical tues_1115_group
Rx16 clinical tues_1115_groupRx16 clinical tues_1115_group
Rx16 clinical tues_1115_group
 
Opioids lecture 08
Opioids lecture 08Opioids lecture 08
Opioids lecture 08
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Basic neurochemistry
Basic neurochemistryBasic neurochemistry
Basic neurochemistry
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Introduction to pharmacology and drug metabolism
Introduction to pharmacology and drug metabolismIntroduction to pharmacology and drug metabolism
Introduction to pharmacology and drug metabolism
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
 
Dr. Leroy Hood Lecuture on P4 Medicine
Dr. Leroy Hood Lecuture on P4 MedicineDr. Leroy Hood Lecuture on P4 Medicine
Dr. Leroy Hood Lecuture on P4 Medicine
 

Ähnlich wie Rx16 workshop 200_group_ppt

Social Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For SlideshareSocial Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For SlideshareMike Newton-Ward
 
Risk comms measurement april 2018
Risk comms measurement april 2018Risk comms measurement april 2018
Risk comms measurement april 2018Paine Publishing
 
Role of digital: social media in consumerism
Role of digital: social media in consumerismRole of digital: social media in consumerism
Role of digital: social media in consumerismCepal & Co.
 
CCS_Capabilities_Presentation_4-21-2016
CCS_Capabilities_Presentation_4-21-2016CCS_Capabilities_Presentation_4-21-2016
CCS_Capabilities_Presentation_4-21-2016Lauren McCormack
 
Future trends in pharma marketing 2016 copie
Future trends in pharma marketing 2016   copieFuture trends in pharma marketing 2016   copie
Future trends in pharma marketing 2016 copieJulien Dagher
 
Content Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare OrganizationsContent Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare OrganizationsAIS Media, Inc.
 
Effective Hospital Participation in the Social Media Conversation Takes Strat...
Effective Hospital Participation in the Social Media Conversation Takes Strat...Effective Hospital Participation in the Social Media Conversation Takes Strat...
Effective Hospital Participation in the Social Media Conversation Takes Strat...MyHealthCommunity Social Media, Inc.
 
Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...Mohammad Shahnewaz
 
WORLD HEALTH COMMUNICATION ASSOCIATES Campaign Develo.docx
WORLD HEALTH COMMUNICATION ASSOCIATES  Campaign Develo.docxWORLD HEALTH COMMUNICATION ASSOCIATES  Campaign Develo.docx
WORLD HEALTH COMMUNICATION ASSOCIATES Campaign Develo.docxambersalomon88660
 
Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009lillianthiemann
 
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn PartnersmHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn PartnersLevi Shapiro
 
1 ESSAYS – Preparation for HS 305 Test 2 1. Let.docx
 1 ESSAYS – Preparation for HS 305 Test 2   1.  Let.docx 1 ESSAYS – Preparation for HS 305 Test 2   1.  Let.docx
1 ESSAYS – Preparation for HS 305 Test 2 1. Let.docxaryan532920
 
7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docxrobert345678
 
Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...
Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...
Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...Amy Cueva
 
Patient Recruitment Insights
Patient Recruitment InsightsPatient Recruitment Insights
Patient Recruitment InsightsDora Calderon
 
Social media and Health communications(pdf).pdf
Social media and Health communications(pdf).pdfSocial media and Health communications(pdf).pdf
Social media and Health communications(pdf).pdfkaanha9828
 
Chapter 12Using the Power of Media to Influence Health Policy .docx
Chapter 12Using the Power of Media to Influence Health Policy .docxChapter 12Using the Power of Media to Influence Health Policy .docx
Chapter 12Using the Power of Media to Influence Health Policy .docxbartholomeocoombs
 
Choose a source of media information written about a health policy i.docx
Choose a source of media information written about a health policy i.docxChoose a source of media information written about a health policy i.docx
Choose a source of media information written about a health policy i.docxjessiep6
 

Ähnlich wie Rx16 workshop 200_group_ppt (20)

Can Social Media Save Lives?
Can Social Media Save Lives?Can Social Media Save Lives?
Can Social Media Save Lives?
 
Social Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For SlideshareSocial Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For Slideshare
 
Risk comms measurement april 2018
Risk comms measurement april 2018Risk comms measurement april 2018
Risk comms measurement april 2018
 
Role of digital: social media in consumerism
Role of digital: social media in consumerismRole of digital: social media in consumerism
Role of digital: social media in consumerism
 
CCS_Capabilities_Presentation_4-21-2016
CCS_Capabilities_Presentation_4-21-2016CCS_Capabilities_Presentation_4-21-2016
CCS_Capabilities_Presentation_4-21-2016
 
Future trends in pharma marketing 2016 copie
Future trends in pharma marketing 2016   copieFuture trends in pharma marketing 2016   copie
Future trends in pharma marketing 2016 copie
 
Content Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare OrganizationsContent Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare Organizations
 
Effective Hospital Participation in the Social Media Conversation Takes Strat...
Effective Hospital Participation in the Social Media Conversation Takes Strat...Effective Hospital Participation in the Social Media Conversation Takes Strat...
Effective Hospital Participation in the Social Media Conversation Takes Strat...
 
Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...
 
WORLD HEALTH COMMUNICATION ASSOCIATES Campaign Develo.docx
WORLD HEALTH COMMUNICATION ASSOCIATES  Campaign Develo.docxWORLD HEALTH COMMUNICATION ASSOCIATES  Campaign Develo.docx
WORLD HEALTH COMMUNICATION ASSOCIATES Campaign Develo.docx
 
Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009
 
PBH.815: Week 1 Lecture Slides
PBH.815: Week 1 Lecture SlidesPBH.815: Week 1 Lecture Slides
PBH.815: Week 1 Lecture Slides
 
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn PartnersmHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
 
1 ESSAYS – Preparation for HS 305 Test 2 1. Let.docx
 1 ESSAYS – Preparation for HS 305 Test 2   1.  Let.docx 1 ESSAYS – Preparation for HS 305 Test 2   1.  Let.docx
1 ESSAYS – Preparation for HS 305 Test 2 1. Let.docx
 
7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx
 
Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...
Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...
Idea2010: Communitiesof Care: Strategic Social Interaction Design for Healthc...
 
Patient Recruitment Insights
Patient Recruitment InsightsPatient Recruitment Insights
Patient Recruitment Insights
 
Social media and Health communications(pdf).pdf
Social media and Health communications(pdf).pdfSocial media and Health communications(pdf).pdf
Social media and Health communications(pdf).pdf
 
Chapter 12Using the Power of Media to Influence Health Policy .docx
Chapter 12Using the Power of Media to Influence Health Policy .docxChapter 12Using the Power of Media to Influence Health Policy .docx
Chapter 12Using the Power of Media to Influence Health Policy .docx
 
Choose a source of media information written about a health policy i.docx
Choose a source of media information written about a health policy i.docxChoose a source of media information written about a health policy i.docx
Choose a source of media information written about a health policy i.docx
 

Mehr von OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyOPUNITE
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorOPUNITE
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasOPUNITE
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinOPUNITE
 

Mehr von OPUNITE (15)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
 

Kürzlich hochgeladen

Call Girl Service in Korba 9332606886 High Profile Call Girls You Can Get ...
Call Girl Service in Korba   9332606886  High Profile Call Girls You Can Get ...Call Girl Service in Korba   9332606886  High Profile Call Girls You Can Get ...
Call Girl Service in Korba 9332606886 High Profile Call Girls You Can Get ...kumargunjan9515
 
Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...gajnagarg
 
Scaling up coastal adaptation in Maldives through the NAP process
Scaling up coastal adaptation in Maldives through the NAP processScaling up coastal adaptation in Maldives through the NAP process
Scaling up coastal adaptation in Maldives through the NAP processNAP Global Network
 
Peace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdf
Peace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdfPeace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdf
Peace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdfNAP Global Network
 
Genuine Call Girls in Salem 9332606886 HOT & SEXY Models beautiful and charm...
Genuine Call Girls in Salem  9332606886 HOT & SEXY Models beautiful and charm...Genuine Call Girls in Salem  9332606886 HOT & SEXY Models beautiful and charm...
Genuine Call Girls in Salem 9332606886 HOT & SEXY Models beautiful and charm...Sareena Khatun
 
2024: The FAR, Federal Acquisition Regulations, Part 32
2024: The FAR, Federal Acquisition Regulations, Part 322024: The FAR, Federal Acquisition Regulations, Part 32
2024: The FAR, Federal Acquisition Regulations, Part 32JSchaus & Associates
 
Tuvalu Coastal Adaptation Project (TCAP)
Tuvalu Coastal Adaptation Project (TCAP)Tuvalu Coastal Adaptation Project (TCAP)
Tuvalu Coastal Adaptation Project (TCAP)NAP Global Network
 
Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...
Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...
Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...Call Girls Mumbai
 
9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts
9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts
9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai EscortsPooja Nehwal
 
Competitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptxCompetitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptxScottMeyers35
 
NAP Expo - Delivering effective and adequate adaptation.pptx
NAP Expo - Delivering effective and adequate adaptation.pptxNAP Expo - Delivering effective and adequate adaptation.pptx
NAP Expo - Delivering effective and adequate adaptation.pptxNAP Global Network
 
Unique Value Prop slide deck________.pdf
Unique Value Prop slide deck________.pdfUnique Value Prop slide deck________.pdf
Unique Value Prop slide deck________.pdfScottMeyers35
 
Coastal Protection Measures in Hulhumale'
Coastal Protection Measures in Hulhumale'Coastal Protection Measures in Hulhumale'
Coastal Protection Measures in Hulhumale'NAP Global Network
 
The NAP process & South-South peer learning
The NAP process & South-South peer learningThe NAP process & South-South peer learning
The NAP process & South-South peer learningNAP Global Network
 
Honasa Consumer Limited Impact Report 2024.pdf
Honasa Consumer Limited Impact Report 2024.pdfHonasa Consumer Limited Impact Report 2024.pdf
Honasa Consumer Limited Impact Report 2024.pdfSocial Samosa
 
Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...
Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...
Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...Delhi Call girls
 
Dating Call Girls inBaloda Bazar Bhatapara 9332606886Call Girls Advance Cash...
Dating Call Girls inBaloda Bazar Bhatapara  9332606886Call Girls Advance Cash...Dating Call Girls inBaloda Bazar Bhatapara  9332606886Call Girls Advance Cash...
Dating Call Girls inBaloda Bazar Bhatapara 9332606886Call Girls Advance Cash...kumargunjan9515
 
Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...
Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...
Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...kumargunjan9515
 

Kürzlich hochgeladen (20)

Call Girl Service in Korba 9332606886 High Profile Call Girls You Can Get ...
Call Girl Service in Korba   9332606886  High Profile Call Girls You Can Get ...Call Girl Service in Korba   9332606886  High Profile Call Girls You Can Get ...
Call Girl Service in Korba 9332606886 High Profile Call Girls You Can Get ...
 
Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Haldia [ 7014168258 ] Call Me For Genuine Models We...
 
Scaling up coastal adaptation in Maldives through the NAP process
Scaling up coastal adaptation in Maldives through the NAP processScaling up coastal adaptation in Maldives through the NAP process
Scaling up coastal adaptation in Maldives through the NAP process
 
Peace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdf
Peace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdfPeace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdf
Peace-Conflict-and-National-Adaptation-Plan-NAP-Processes-.pdf
 
Genuine Call Girls in Salem 9332606886 HOT & SEXY Models beautiful and charm...
Genuine Call Girls in Salem  9332606886 HOT & SEXY Models beautiful and charm...Genuine Call Girls in Salem  9332606886 HOT & SEXY Models beautiful and charm...
Genuine Call Girls in Salem 9332606886 HOT & SEXY Models beautiful and charm...
 
2024: The FAR, Federal Acquisition Regulations, Part 32
2024: The FAR, Federal Acquisition Regulations, Part 322024: The FAR, Federal Acquisition Regulations, Part 32
2024: The FAR, Federal Acquisition Regulations, Part 32
 
Tuvalu Coastal Adaptation Project (TCAP)
Tuvalu Coastal Adaptation Project (TCAP)Tuvalu Coastal Adaptation Project (TCAP)
Tuvalu Coastal Adaptation Project (TCAP)
 
Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...
Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...
Bhubaneswar Call Girls Bhubaneswar 👉👉 9777949614 Top Class Call Girl Service ...
 
9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts
9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts
9867746289 Independent Call Girls in Mumbai Airport 24/7 - Mumbai Escorts
 
Competitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptxCompetitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptx
 
NAP Expo - Delivering effective and adequate adaptation.pptx
NAP Expo - Delivering effective and adequate adaptation.pptxNAP Expo - Delivering effective and adequate adaptation.pptx
NAP Expo - Delivering effective and adequate adaptation.pptx
 
Unique Value Prop slide deck________.pdf
Unique Value Prop slide deck________.pdfUnique Value Prop slide deck________.pdf
Unique Value Prop slide deck________.pdf
 
Coastal Protection Measures in Hulhumale'
Coastal Protection Measures in Hulhumale'Coastal Protection Measures in Hulhumale'
Coastal Protection Measures in Hulhumale'
 
The NAP process & South-South peer learning
The NAP process & South-South peer learningThe NAP process & South-South peer learning
The NAP process & South-South peer learning
 
Honasa Consumer Limited Impact Report 2024.pdf
Honasa Consumer Limited Impact Report 2024.pdfHonasa Consumer Limited Impact Report 2024.pdf
Honasa Consumer Limited Impact Report 2024.pdf
 
Sustainability by Design: Assessment Tool for Just Energy Transition Plans
Sustainability by Design: Assessment Tool for Just Energy Transition PlansSustainability by Design: Assessment Tool for Just Energy Transition Plans
Sustainability by Design: Assessment Tool for Just Energy Transition Plans
 
Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...
Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...
Vivek @ Cheap Call Girls In Kamla Nagar | Book 8448380779 Extreme Call Girls ...
 
AHMR volume 10 number 1 January-April 2024
AHMR volume 10 number 1 January-April 2024AHMR volume 10 number 1 January-April 2024
AHMR volume 10 number 1 January-April 2024
 
Dating Call Girls inBaloda Bazar Bhatapara 9332606886Call Girls Advance Cash...
Dating Call Girls inBaloda Bazar Bhatapara  9332606886Call Girls Advance Cash...Dating Call Girls inBaloda Bazar Bhatapara  9332606886Call Girls Advance Cash...
Dating Call Girls inBaloda Bazar Bhatapara 9332606886Call Girls Advance Cash...
 
Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...
Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...
Delivery in 20 Mins Call Girls Malappuram { 9332606886 } VVIP NISHA Call Girl...
 

Rx16 workshop 200_group_ppt

  • 1. Using Digital and Social Media to Influence the #RxProblem Presenters: • Rosemary Bretthauer-Mueller, Digital and Social Marketing Lead, National Center for Injury Prevention and Control, CDC • Erin Connelly, MPA, Associate Director of Communication, National Center for Injury Prevention and Control, CDC • Cassie Strawn, MA, Health Communication Specialist, National Center for Injury Prevention and Control, CDC A Centers for Disease Control and Prevention Training:
  • 2. Disclosures Erin Connelly, MPAff; Cassie Strawn, MA; and Rosie Bretthauer-Mueller have disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services
  • 3. Disclosures • All planners/managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. • The following planners/managers have the following to disclose: – John J. Dreyzehner, MD, MPH, FACOEM – Ownership interest: Starfish Health (spouse) – Robert DuPont – Employment: Bensinger, DuPont & Associates-Prescription Drug Research Center
  • 4. Learning Objectives 1. Explain the value and use of general communication principles, planning and tactics. 2. Demonstrate the basic processes of establishing, maintaining and using social media channels. 3. Identify social media best practices, with potential opportunities to expand knowledge and refine use of channels. 4. Describe the application of social media to help address public health issues. 5. Explain how to prepare to use social media to impact the #RxProblem.
  • 5. Erin Connelly Rosie Bretthauer-Mueller Cassie Strawn Introductions
  • 6. Agenda 2:00 pm: Surveys; Introductions; Opioid Overdose Epidemic Overview; Health Communication Basics; Discussion & Questions 2:50 pm: Break 3:00 pm: Survey results; Social Media: Basics to Best Practices; Case Study: #RxProblem; Discussion & Questions 3:50 pm: Break 4:00 pm: Small group exercise; Discussion & Questions 4:50 pm: Wrap up
  • 8. Nearly a half million people have died from drug overdoses in the United States from 2000 to 2014. Americans die every day from an opioid overdose— including prescription opioids and heroin.78 249 million prescriptions were written in 2013—enough for every adult American to have a bottle of pills.
  • 9.
  • 10. Opioid Abuse Related Health Issues  Resurgence of infections like Hepatitis C and HIV among persons who inject drugs  Increased sexual risk behavior in youth who misuse and abuse RX drugs
  • 11. Reducing Viral Hepatitis Cases Associated with Drug-Use Behaviors  To ensure that persons who inject drugs have access to viral hepatitis prevention, care and treatment services, a comprehensive approach is needed, including: – Regular HBV and HCV testing – Rapid links to care and treatment – Access to substance abuse treatment, risk reduction counseling and sterile injection equipment 111 3 79 106 185 HIV-, HCV- HIV+, HCV- HIV+, HCV+ HIV-, HCV+ HIV HCV Outbreak, Scott County,Indiana,2014-2015
  • 12. Non-medical use of prescription drugs among adolescents  Preventing drug use among adolescents is a priority area for the Division of Adolescent and School Health (DASH) at CDC. – Substance abuse has been associated with behaviors that increase the risk for HIV, sexually transmitted infections (STIs) and pregnancy.  In 2011, DASH added a question to the National Youth Risk Behavior Survey (YRBS) to determine prevalence of non- medical use of prescription drugs among our nation’s high school students.  Data from the 2013 YRBS indicate that about 1 out of 6 high school students have used prescription drugs without a doctor’s prescription.
  • 13. Public health, law enforcement & communities working together cut crash deaths by more than half... We can do the same for overdoses 0 5 10 15 20 25 Deathsper100,000population Motor Vehicle Traffic Drug Poisoning (Overdose)
  • 14. CDC’s Science and Solutions  Protect the public by tracking trends in the epidemic  Help states scale up prevention efforts that work  Improve patient safety by providing doctors with data and guidance for evidence-based decision-making
  • 16. Using Communication to Raise Awareness
  • 17. And to Promote Solutions www.cdc.gov/drugoverdose
  • 19. Health Communication Workshop Objectives:  Define health communication and convey its value  Understand where health communication fits as an organizational strategy and as a public health intervention  Discuss basic steps involved with executing a health communication strategy  Identify the benefits of starting with social media activities
  • 20. What is Health Communication? Using integrated strategies to design and deliver messages to inform and influence individual and community decisions that enhance health.
  • 21. Health communication helps us confront overwhelming public health challenges.
  • 22. Health communication is more than just PSAs, brochures, and presentations. Information is giving out. Communication is getting through. – Sydney J. Harris
  • 23. Setting the context: where does health communication fit internally? Think about your vision, mission and values.
  • 24. Where does health communication fit internally? Objectives Strategies Goals Tactics (The way it will be) (Bringing goals to life) (Getting the job done) (The path to success)
  • 25. Where does health communication fit externally? American Journal of Public Health.2010 Apr; 100(4):590-5 Counseling and Education Clinical Interventions Long-Lasting Protective Interventions Changing the Context To make individuals’ default decisions healthy Socioeconomic Factors Increasing Population Impact Increasing Individual Effort Needed
  • 26. A Campaign That Targets Everyone Targets No One  No one has unlimited funds.  Can’t be everything to everyone.  Must prioritize goals, audiences, messages, channels.  Focus on a few things each year, set realistic expectations, and plan evaluation accordingly.
  • 27. Now that we have a solid definition and some valuable context… Let’s get started.
  • 28. National Cancer Institute: Making health communication programs work: A planner’s guide. Rev. ed. 1 2 3 4
  • 29. Planning and Strategy Development  Review background information to define the problem: what’s out there?  Set communication objectives: what do you want to accomplish?  Identify primary (and secondary) target audiences: who do you want to reach?
  • 30. Developing and Pre-testing Concepts, Messages and Materials  Develop and pretest message concepts: what do you want to say?  Select communication channels: where do you want to say it?  Select, create and pretest messages and products: how do you want to say it?
  • 31. Implement the Program  Develop a promotion and production plan: how do you get it used?  Implement communication strategies: get it out there.
  • 32. Assess Effectiveness and Make Refinements  Conduct process evaluation: tweak and refine.  Conduct outcome and impact evaluation: how well did we do?
  • 33. In Summary, Communication Efforts Work Best When They:  Are integrated into a comprehensive program  Are based on audience research and pretesting  Achieve adequate message exposure  Make strategic use of earned and social media  Leverage the power of good storytelling
  • 34. Why focus on social media?  It’s accessible  It can be inexpensive  It has the potential for large viral reach with the right content  It is not going away
  • 36. SOCIAL MEDIA: basics to best practices
  • 37. Why Social Media for the #RxProblem?  It’s EASY. (Well…)  It’s FREE. (Or is it?)  You have the capacity to do it (Hmm…?)
  • 38. It’s EASY. (Well…)  Make the case to your leadership  Have a plan – If you build it, will they come? – Listening – Engaging – Policies
  • 39. Make the case: Who is using social media? Everybody  76% of online adults use social media – 72% use Facebook – 28% use Instagram – 23% use Twitter – 31% use Pinterest – 25% use LinkedIn Everyday  Social media users are vigilant – 70% of Facebook users use it daily – 49% of Instagram users use it daily – 36% of Twitter users use it daily
  • 40. Make the case: It’s not just cat videos.  Got their news from Facebook – 63% in 2015 – 47% in 2013  Got their news from Twitter – 63% in 2015 – 52% in 2013
  • 41. Make the case: What can it do for you?  Real-time events and info  Raise awareness  Connect with your audience  Expand your reach  Build new relationships  Foster conversations  Harness collective energy  Support victims, survivors  Respond to those in need
  • 42. Have a plan: What do you want to accomplish?  First, which kind of social media account is right for you? – Who is your audience? – What sort of information do they want? – What is their preferred social media channel? – What social media channel(s) can you reasonably launch and maintain?
  • 43. Have a plan: Which type of account? Organization  Official voice  Organizational content and security guidelines  Promote your success  Share expertise and resources Professional Individual  Face, name, voice  Personal, identifiable  Connect with emotions  Organizational rules, nuances
  • 44. Building Followers  Let your partners know where you will soon be on social media  Pair the launch of your social media channel with a major campaign, meeting, conference  Use other forms of communication to amplify your new channel – Email signature blocks – Presentations – Email / newsletters
  • 45. Listen, Before You Speak  Find out who else uses your chosen social media channel  Like and/or follow them  Who is already using social media for the #RxProblem?
  • 46. Listen, Before You Speak  Watch conversations about your organization/topics – Note the questions, opinions, misinformation for content opportunities  Subscribe to Lists from trusted partners  Search relevant topics through keywords and hashtags
  • 47. Plan, Before You Engage  Types – Likes – Shares/retweets – Comments – Nothing/ignore  Process to triage/clear responses  Decision tree/criteria – Positive or negative? – Worth acknowledging? – Appropriate to respond? – Add value to conversation? – Have the content to respond? – Correct misinformation? Observing Following Engaging Endorsing Contributing
  • 48. Policies Are Part of Your Plan  Disclaimers – External comments do not represent you – Shares do not equal endorsements  Subject to FOIA notices  Maintain respectful environment by removing – Hate speech – Profanity, obscenity or vulgarity – Defamation – Name calling and/or personal attacks – Comments whose main purpose is to sell a product – Comments that infringe on copyrights
  • 49. It’s FREE. (Or is it?)  Content development  Monitoring tools  Advertising  Staff resources
  • 50. Content  It has to be compelling to build a following  People share when it makes them look: – Funny – First-to-know – Smart…very smart
  • 51. Content  If people are looking at Facebook or Twitter every day, you need content every day.  You need more content than you think.  More than that even.
  • 52. What are people looking for on social media?
  • 53. What are people looking for on social media?
  • 54. Keep This in Mind  Know what works on the channel  Keep it simple  Watch your tone  Create ways for people to engage  Use social media tricks and tools  STAY ON MESSAGE
  • 55. Keep This in Mind  Create ongoing, engaging content  Dedicate resources to create visual content  Create content that helps build a community, highlighting partners and leaders in the field  Create crowdsourced content through coordinated events
  • 56. Monitoring Tools  Free  Kinda free  Not free
  • 57. Monitoring Tools  Free  Kinda free  Not free
  • 58. Monitoring Tools  Free  Kinda free  Not free
  • 59. Why Monitor and Evaluate?  Review what the audience wants and respond  Make data-based decisions  Gauge success  Improve performance of posts  Save cost, effective use of staff hours
  • 60. What are we really measuring?  Exposure: Visits, views, followers, fans, subscribers, brand mentions  Engagement: Clicks, retweets, shares, replies, messages, posts, comments  Actions: Downloads, attendees, success stories, leads  Influence: Share of voice, sentiment, other influencers
  • 61. Monitor to Know your Audience  Who are your followers and what do they want?  What brings in your audiences?  How much has your audience grown?  How do they respond to your content?
  • 62. You have the capacity.  Get started in social media to your comfort level  Participate in your organization’s social media process  Follow your partners/professionals in the field  Follow/use professional events’ hashtags  Learn how you can benefit from tying your social media presence your prevention  Assess your social media persona before reaching out to a professional audience
  • 64. Case Study: #RxProblem  Challenged to help reach influencers  No resources, short timeline  Sharable starter content  Decisions about audience, hashtags  One chance to launch
  • 65. Intended Audiences Who to engage online?  people whose lives affected  public health allies  coalitions and organizations Who to influence?  influencers of safer prescribing  medical and health professionals  community leaders
  • 66. Outcomes  Engage decision makers  Visibility  Volume  Tone  Quality, appeal  Create a feeling more than educate
  • 69. THANK YOU #RxProblem @CDCInjury @DebHouryCDC CDC.gov/DrugOverdose CDC’s Injury Center Office of Communication The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention.
  • 70. Using Digital and Social Media to Influence the #RxProblem Presenters: • Rosemary Bretthauer-Mueller, Digital and Social Marketing Lead, National Center for Injury Prevention and Control, CDC • Erin Connelly, MPA, Associate Director of Communication, National Center for Injury Prevention and Control, CDC • Cassie Strawn, MA, Health Communication Specialist, National Center for Injury Prevention and Control, CDC A Centers for Disease Control and Prevention Training: